Pharmazz is a privately held company developing novel products in critical care medicine. The U.S. Food and Drug Administration (FDA) has approved two phase III INDs for Centhaquine as an agent for hypovolemic shock and Sovateltide for cerebral ischemic stroke. In addition, Pharmazz obtained marketi...
Use this information to figure out if this company is an ideal customer for you.
630-780-6087
50 W 75th Street
Willowbrook, 60527
201 - 500 Employees
$1M - $5M
linkedin.com/company/pharmazz
Pharmazz Inc.’s CEO is Anil Gulati
Pharmazz Inc.’s HQ is located at 50 W 75th Street, Willowbrook
Pharmazz Inc.’s phone number is 630-780-6087
Pharmazz Inc.’s official website is pharmazz.com
Pharmazz Inc.’s revenue is $1M - $5M
Pharmazz Inc. has 201 - 500 employees
Pharmazz Inc. is in the industry of: Pharmaceuticals
